According to a new report from Intel Market Research, the global Hormone Infusion Pump market was valued at USD 402 million in 2025 and is projected to reach USD 656 million by 2034, growing at a robust CAGR of 7.5% during the forecast period (2025–2034). This growth is driven by the rising prevalence of chronic endocrine diseases, rapid technological advancements in pump miniaturization,...

Leading players in the Infusion Pump Market include Becton Dickinson, Baxter International, B. Braun, and Fresenius Kabi with strong market positions. These established companies invest heavily in R&D to develop next-generation platforms with enhanced safety features and connectivity. Strategic partnerships between device manufacturers and software firms accelerate digital health...

The Europe Medical Drug‑releasing Micropump market was valued at USD 0.35 billion in 2025 and is projected to grow from USD 0·38 billion in 2026 to USD 0·64 billion by 2034, exhibiting a CAGR of 9·3% during the forecast period. A Medical Drug‑releasing Micropump is a miniature infusion device designed for precise, controlled, and continuous drug delivery. These systems...